NVST on NYSE
Envista Holdings Corporation
Dental business.1
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Dentsply Sirona, SmileDirectClub or Sonendo (United States), or pick any stock.
- TickerNVST on NYSE1
- IndustryDental Equipment & Supplies1
- HeadquartersBrea1
- Websiteenvistaco.com
- Legal formDelaware corporation1
- Incorporated inDE4
- Business address200 S. Kraemer Blvd., Bldg. E, Brea, Ca 928214
- Filer categoryLarge accelerated filer4
- LEI549300BX623VURJZ52693
- StatusActive3
- LEI statusIssued and current3
- Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States3
- Registered withDivision of Corporations, Department of State, 70346243
See how the biggest companies compare on our leaderboards

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention, and loupes.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Specialty Products and Technologies brought in 64% of the revenue Envista Holdings Corporation broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Specialty Products and Technologies | $1.6B | $1.6B | $1.8B |
| Equipment and Consumables | $924.1M | $894.2M | $966.7M |
Regions
United States brought in 32% of the revenue Envista Holdings Corporation broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $1.2B | $1.2B | $1.3B |
| All Other Countries | $1.2B | $1.1B | $1.2B |
| Western Europe | $546.0M | $615.3M | |
| High-Growth Markets | $539.0M | $586.2M | |
| China | $205.7M | $193.5M | $194.4M |
| Other Developed Markets | $120.3M | $122.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue45¢$1.2B
- Research and development4¢$114.0M
- Selling, general and admin43¢$1.2B
- Other costs1¢$38.9M
- Income tax5¢$130.2M
- Profit2¢$47.0M
Out of $2.7B in revenue.7
Where each dollar of operating cash went, fiscal 2025
- Capital spending16¢$45.3M
- Kept or used elsewhere84¢$230.4M
Out of $275.7M of cash from operations.7
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | $2.7B | $2.5B | $2.6B |
| Cost of sales | $1.2B | $1.1B | $1.1B |
| Gross profit | $1.5B | $1.4B | $1.4B |
| Selling, general and administrative | $1.2B | $1.2B | $1.1B |
| Research and development | $114.0M | $99.1M | $93.8M |
| Goodwill and intangible asset impairments | $0 | $1.2B | $258.3M |
| Operating profit (loss) | $216.1M | -$1.0B | $31.5M |
| Other expense, net | -$2.3M | -$100.0K | -$23.0M |
| Interest expense, net | -$36.6M | -$46.4M | -$63.4M |
| Income (loss) before income taxes | $177.2M | -$1.1B | -$54.9M |
| Income tax expense | $130.2M | $33.9M | $45.3M |
| Net income (loss) | $47.0M | -$1.1B | -$100.2M |
| Earnings (Loss) - basic (in USD per share) | $0.28 | -$6.50 | -$0.60 |
| Earnings (Loss) - diluted (in USD per share) | $0.28 | -$6.50 | -$0.60 |
| Basic (in shares) | 168.0M shares | 172.2M shares | 166.9M shares |
| Diluted (in shares) | 169.2M shares | 172.2M shares | 166.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.2B | $1.1B | ||
| Trade accounts receivable, less allowance for credit losses of $22.5 and $26.6, respectively | $429.6M | $363.0M | ||
| Inventories, net | $288.1M | $241.0M | ||
| Prepaid expenses and other current assets | $97.2M | $115.2M | ||
| Total current assets | $2.0B | $1.8B | ||
| Property, plant and equipment, net | $296.8M | $277.0M | ||
| Operating lease right-of-use assets | $142.1M | $142.8M | ||
| Other long-term assets | $228.1M | $230.6M | ||
| Goodwill, net | $2.4B | $2.3B | ||
| Other intangible assets, net | $627.2M | $649.9M | ||
| Total assets | $5.7B | $5.4B | ||
| Short-term debt | $0 | $116.0M | ||
| Trade accounts payable | $191.6M | $174.6M | ||
| Accrued expenses and other liabilities | $622.0M | $553.6M | ||
| Operating lease liabilities | $39.0M | $34.5M | ||
| Total current liabilities | $852.6M | $878.7M | ||
| Operating lease liabilities | $110.4M | $118.9M | ||
| Other long-term liabilities | $161.4M | $139.8M | ||
| Long-term debt | $1.4B | $1.3B | ||
| Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 500.0 million shares authorized; 175.4 million shares issued and 163.8 million shares outstanding at December 31, 2025; 174.2 million shares issued and 172.2 million shares outstanding at December 31, 2024 | $1.8M | $1.7M | ||
| Treasury stock at cost; 11.6 million shares and 2.0 million shares at December 31, 2025 and December 31, 2024, respectively | -$224.5M | -$50.5M | ||
| Additional paid-in capital | $3.9B | $3.8B | ||
| Accumulated deficit | -$440.4M | -$487.4M | ||
| Accumulated other comprehensive loss | -$113.2M | -$371.1M | ||
| Total stockholders equity | $3.1B | $2.9B | $4.2B | $4.2B |
| Total liabilities and stockholders equity | $5.7B | $5.4B | ||
| Allowance for credit losses | $22.5M | $26.6M | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred shares authorized (in shares) | 15.0M shares | 15.0M shares | ||
| Preferred shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued (in shares) | 175.4M shares | 174.2M shares | ||
| Common stock, shares outstanding (in shares) | 163.8M shares | 172.2M shares | ||
| Treasury stock at cost (in shares) | 11.6M shares | 2.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.2B | $1.1B | ||
| Trade accounts receivable, less allowance for credit losses of $22.5 and $26.6, respectively | $429.6M | $363.0M | ||
| Inventories, net | $288.1M | $241.0M | ||
| Prepaid expenses and other current assets | $97.2M | $115.2M | ||
| Total current assets | $2.0B | $1.8B | ||
| Property, plant and equipment, net | $296.8M | $277.0M | ||
| Operating lease right-of-use assets | $142.1M | $142.8M | ||
| Other long-term assets | $228.1M | $230.6M | ||
| Goodwill, net | $2.4B | $2.3B | ||
| Other intangible assets, net | $627.2M | $649.9M | ||
| Total assets | $5.7B | $5.4B | ||
| Short-term debt | $0 | $116.0M | ||
| Trade accounts payable | $191.6M | $174.6M | ||
| Accrued expenses and other liabilities | $622.0M | $553.6M | ||
| Operating lease liabilities | $39.0M | $34.5M | ||
| Total current liabilities | $852.6M | $878.7M | ||
| Operating lease liabilities | $110.4M | $118.9M | ||
| Other long-term liabilities | $161.4M | $139.8M | ||
| Long-term debt | $1.4B | $1.3B | ||
| Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 500.0 million shares authorized; 175.4 million shares issued and 163.8 million shares outstanding at December 31, 2025; 174.2 million shares issued and 172.2 million shares outstanding at December 31, 2024 | $1.8M | $1.7M | ||
| Treasury stock at cost; 11.6 million shares and 2.0 million shares at December 31, 2025 and December 31, 2024, respectively | -$224.5M | -$50.5M | ||
| Additional paid-in capital | $3.9B | $3.8B | ||
| Accumulated deficit | -$440.4M | -$487.4M | ||
| Accumulated other comprehensive loss | -$113.2M | -$371.1M | ||
| Total stockholders equity | $3.1B | $2.9B | $4.2B | $4.2B |
| Total liabilities and stockholders equity | $5.7B | $5.4B | ||
| Allowance for credit losses | $22.5M | $26.6M | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred shares authorized (in shares) | 15.0M shares | 15.0M shares | ||
| Preferred shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued (in shares) | 175.4M shares | 174.2M shares | ||
| Common stock, shares outstanding (in shares) | 163.8M shares | 172.2M shares | ||
| Treasury stock at cost (in shares) | 11.6M shares | 2.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $47.0M | -$1.1B | -$100.2M |
| Depreciation | $40.1M | $40.8M | $36.0M |
| Amortization | $75.9M | $82.3M | $99.6M |
| Allowance for credit losses | $9.5M | $17.9M | $7.1M |
| Stock-based compensation expense | $37.6M | $35.3M | $30.7M |
| Gain on investments in rabbi trust, net | -$3.8M | -$700.0K | $0 |
| Loss (gain) on equity investments, net | $6.2M | $1.1M | -$3.6M |
| Loss (gain) on sale of property, plant and equipment | $1.8M | $2.8M | -$5.4M |
| Restructuring charges | $0 | $0 | $1.3M |
| Goodwill and intangible asset impairments | $0 | $1.2B | $258.3M |
| Fixed assets impairments and other charges | $2.2M | $17.1M | $200.0K |
| Non-cash operating lease costs | $34.7M | $31.4M | $27.0M |
| Inducement expense related to exchange of convertible notes | $0 | $0 | $28.5M |
| Amortization of debt discount and issuance costs | $4.2M | $4.9M | $4.6M |
| Deferred income taxes | $11.4M | -$29.0M | -$37.0M |
| Change in trade accounts receivable | -$48.5M | $10.0M | -$17.0M |
| Change in inventories | -$29.1M | $3.6M | $35.1M |
| Change in trade accounts payable | $7.5M | -$1.2M | -$46.3M |
| Change in prepaid expenses and other assets | $7.7M | -$6.7M | $3.3M |
| Change in accrued expenses and other liabilities | $116.0M | $134.5M | -$12.0M |
| Change in operating lease liabilities | -$44.7M | -$42.8M | -$34.5M |
| Net cash provided by operating activities | $275.7M | $336.5M | $275.7M |
| Payments for additions to property, plant and equipment | -$45.3M | -$33.8M | -$58.2M |
| Purchases of investments held in rabbi trust | -$9.9M | -$32.8M | $0 |
| Proceeds from sale of investments held in rabbi trust | $10.4M | $9.3M | $0 |
| Proceeds from sales of property, plant and equipment | $500.0K | $100.0K | $6.1M |
| Proceeds from sale of equity investment | $0 | $400.0K | $10.7M |
| All other investing activities, net | -$6.8M | $2.2M | -$21.0M |
| Net cash used in investing activities | -$51.1M | -$54.6M | -$62.4M |
| Proceeds from stock option exercises | $2.8M | $2.4M | $11.3M |
| Cash paid for treasury stock | -$166.6M | $0 | $0 |
| Tax withholding payment related to net settlement of equity awards | -$6.2M | -$5.3M | -$7.9M |
| Proceeds from issuance of convertible notes due 2028 | $0 | $0 | $500.2M |
| Principal paid related to exchange of convertible notes due 2025 | -$116.3M | $0 | -$401.2M |
| Proceeds from borrowings | $0 | $0 | $323.5M |
| Repayment of borrowings | $0 | -$100.0M | -$288.8M |
| Proceeds from revolving line of credit | $115.4M | $0 | $0 |
| All other financing activities | $0 | -$800.0K | $100.0K |
| Net cash (used in) provided by financing activities | -$170.9M | -$103.7M | $118.9M |
| Effect of exchange rate changes on cash and cash equivalents | $88.9M | -$49.1M | $900.0K |
| Net change in cash and cash equivalents | $142.6M | $129.1M | $333.1M |
| Cash paid for interest | $46.1M | $54.7M | $63.2M |
| Cash paid for taxes | $79.8M | $32.9M | $98.6M |
| ROU assets obtained in exchange for operating lease obligations | $24.8M | $54.8M | $22.1M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Envista Holdings Corporation, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerPaul A. Keel May 2, 2024 to now15
- Chief executive officerAmir Aghdaei Sep 17, 2019 to Feb 27, 202416
- PresidentRobert Befidi Feb 21, 2024 to Nov 25, 202417
- PresidentStefan Nilsson Nov 25, 2024 to now18
- PresidentVeronica Acurio Nov 25, 2024 to now19
- PresidentAmir Aghdaei Sep 17, 2019 to Jul 17, 202016
- Chief financial officerEric D. Hammes Aug 13, 2024 to now20
- Chief financial officerHoward H. Yu Sep 17, 2019 to Sep 18, 202321
Board members and other officers (24)
- CAOCoree K. Thomas Aug 13, 2026 to now22
- SVP, OrthodonticsEric Conley Feb 22, 2023 to May 29, 202423
- Chief Accounting OfficerFaez C. Kaabi Oct 2, 2023 to now24
- SENIOR VICE PRESIDENTJean-Claude Kyrillos Feb 26, 2020 to Apr 6, 202325
- Senior Vice President, CHROCurt W. Bludworth Sep 20, 2019 to Mar 2, 202226
- Senior Vice PresidentHans Geiselhoeringer Sep 20, 2019 to Feb 26, 202027
- Senior Vice PresidentJeffrey Kappler Sep 20, 2019 to Nov 19, 202128
- Vice President, CAOKari Lyn Moore Sep 20, 2019 to Mar 1, 202229
- Senior Vice PresidentMischa Reis Sep 20, 2019 to now30
- Senior Vice PresidentPatrik Eriksson Sep 20, 2019 to Sep 18, 202331
- Board memberJames Andrew Pierce Jul 16, 2025 to now32
- Board memberPaul A. Keel May 2, 2024 to now15
- Board memberBarbara B. Hulit Dec 3, 2021 to now33
- Board memberTeresa Gayle Sheppard Aug 3, 2020 to May 27, 202134
- Board memberAmir Aghdaei Sep 17, 2019 to Feb 27, 202416
- Board memberDaniel Raskas Sep 17, 2019 to now35
- Board memberWilliam K. Daniel Sep 17, 2019 to Dec 20, 201936
- Board memberAllison F. Blackwell Sep 20, 2019 to Sep 20, 201937
- Board memberChristine A. Tsingos Sep 20, 2019 to now38
- Board memberDan Houghton Sep 20, 2019 to Sep 20, 201939
- Board memberJonathan O. Clark Sep 20, 2019 to Sep 20, 201940
- Board memberR. Scott Huennekens Sep 20, 2019 to now41
- Board memberWendy Carruthers Sep 20, 2019 to now42
- Board memberKieran Gallahue Dec 20, 2019 to now43
Subsidiaries and ownership
Subsidiaries
- Kerr Corporation since 2022
From Wikidata.1
Acquisitions
- 2022Acquired Kerr Corporation1
- 2019Acquired KaVo Dental1
Timeline
Filings
340 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 55 major events, 190 insider forms, 38 large holders, 37 other. The latest 20:
- Sep 17, 20268-K EDGAR
- Aug 27, 20264 EDGAR
- Aug 27, 20264 EDGAR
- Aug 27, 20264 EDGAR
- Aug 27, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 20, 2026144 EDGAR
- Aug 20, 20264 EDGAR
- Aug 20, 20264 EDGAR
- Aug 19, 20268-K EDGAR
- Aug 13, 20263 EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Jun 3, 20268-K EDGAR
- May 28, 2026SD EDGAR
- May 27, 20264 EDGAR
- May 21, 20264 EDGAR
- May 21, 20268-K EDGAR
- May 21, 20264 EDGAR
- May 21, 20264 EDGAR
The 340 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
36 open-market trades by officers, directors and large owners since October 2021: 6 buys and 30 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 8,000 | $27.50 | $220.0K | Form 4 |
| Feb 10, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 9,675 | $30.00 | $290.2K | Form 4 |
| Aug 25, 2025 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 15,000 | $21.60 | $324.0K | Form 4 |
| Aug 13, 2024 | Keel Paul AChief Executive Officer | Buy | 30,000 | $16.87 | $506.1K | Form 4 |
| Aug 12, 2024 | Hammes Eric D.Chief Financial Officer | Buy | 24,532 | $16.33 | $400.6K | Form 4 |
| Nov 16, 2023 | Conley EricSVP, Orthodontics | Buy | 2,185 | $22.89 | $50.0K | Form 4 |
| Nov 8, 2023 | Nance Mark EGeneral Counsel | Buy | 5,000 | $21.75 | $108.8K | Form 4 |
| Nov 6, 2023 | Aghdaei AmirChief Executive Officer | Buy | 10,000 | $21.53 | $215.3K | Form 4 |
| Nov 6, 2023 | Keller StephenPrincipal Financial Officer | Buy | 2,000 | $21.53 | $43.1K | Form 4 |
| Feb 28, 2023 | Yu Howard HChief Financial Officer | Sale | 10,016 | $37.90 | $379.6K | Form 4 |
| Nov 17, 2022 | Yu Howard HChief Financial Officer | Sale | 657 | $36.55 | $24.0K | Form 4 |
| Apr 18, 2022 | Yu Howard HChief Financial Officer | Sale | 5,341 | $45.73 | $244.2K | Form 4 |
| Mar 29, 2022 | Aghdaei AmirChief Executive Officer | Sale | 10,538 | $51.66 | $544.4K | Form 4 |
| Mar 21, 2022 | Aghdaei AmirChief Executive Officer | Sale | 114,702 | $50.85 | $5.8M | Form 4 |
| Mar 21, 2022 | Yu Howard HChief Financial Officer | Sale | 4,786 | $50.86 | $243.4K | Form 4 |
| Mar 18, 2022 | Aghdaei AmirChief Executive Officer | Sale | 10,538 | $49.66 | $523.3K | Form 4 |
| Mar 18, 2022 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 10,092 | $50.00 | $504.6K | Form 4 |
| Mar 18, 2022 | Yu Howard HChief Financial Officer | Sale | 19,752 | $50.04 | $988.4K | Form 4 |
| Mar 17, 2022 | Aghdaei AmirChief Executive Officer | Sale | 114,702 | $49.01 | $5.6M | Form 4 |
| Mar 16, 2022 | Aghdaei AmirChief Executive Officer | Sale | 14,050 | $47.66 | $669.6K | Form 4 |
All 36 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Morgan StanleySCHEDULE 13G/A, 7 filings Dec 10, 2021 to May 11, 202644
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202645
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 26, 202646
- FRANKLIN MUTUAL ADVISERS LLCSCHEDULE 13G/A, 2 filings Aug 5, 2025 to Jan 29, 202647
- HARRIS ASSOCIATES L PSCHEDULE 13G/A, 4 filings Feb 11, 2022 to Aug 14, 202548
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G, 1 filing Jul 15, 202549
- AMERICAN CENTURY INVESTMENT MANAGEMENT INCSCHEDULE 13G/A, 2 filings Nov 8, 2024 to Feb 14, 202550
- ARIEL INVESTMENTS, LLCSCHEDULE 13G, 1 filing Nov 12, 202451
- LAZARD ASSET MANAGEMENT LLCSC 13G/A, 4 filings Mar 8, 2023 to Feb 15, 202452
- FMR LLCSC 13G/A, 4 filings Feb 9, 2022 to Feb 9, 202453
- MFS Investment ManagementSC 13G/A, 2 filings Feb 8, 2023 to Feb 9, 202454
- PRICE T ROWE ASSOCIATES INC /MD/SC 13G/A, 1 filing Feb 14, 202255
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 18,437,542 | $485.8M | 0.0% | +584,715 |
| Ariel Investments, LLC | 9,818,177 | $258.7M | 2.6% | −1,045,415 |
| Dimensional Fund Advisors LP | 9,566,949 | $252.1M | 0.0% | −213,999 |
| Vanguard Portfolio Management LLC | 7,487,670 | $197.3M | 0.0% | −79,051 |
| Vanguard Capital Management LLC | 7,337,916 | $193.4M | 0.0% | +19,335 |
| Morgan Stanley | 6,436,043 | $169.6M | 0.0% | −2,357,094 |
| Gates Capital Management, Inc. | 5,552,383 | $146.3M | 4.8% | +189,672 |
| State Street Corp | 5,329,275 | $140.5M | 0.0% | +100,517 |
| Alliancebernstein L.P. | 5,213,644 | $132.3M | 0.0% | +185,033 |
| Arrowstreet Capital, Limited Partnership | 4,847,940 | $127.7M | 0.1% | +1,989,647 |
| Franklin Resources Inc | 4,810,040 | $126.7M | 0.0% | −2,083,985 |
| Victory Capital Management Inc | 4,494,346 | $118.4M | 0.1% | +101,278 |
| Ilex Capital Partners (UK) LLP | 4,372,709 | $115.2M | 2.4% | New |
| Quantinno Capital Management LP | 4,194,886 | $110.5M | 0.1% | +1,499,916 |
| Aqr Capital Management LLC | 4,023,691 | $106.0M | 0.0% | +1,405,574 |
| Neuberger Berman Group LLC | 3,876,747 | $102.2M | 0.1% | +3,864,108 |
| Fuller & Thaler Asset Management, Inc. | 3,642,097 | $96.0M | 0.3% | −131,655 |
| Jpmorgan Chase & Co | 3,304,946 | $89.5M | 0.0% | +388,702 |
| Geode Capital Management, LLC | 3,150,508 | $83.0M | 0.0% | +1,213 |
| American Century Companies Inc | 3,052,519 | $80.4M | 0.0% | −149,107 |
| Massachusetts Financial Services Co /ma/ | 2,913,844 | $78.5M | 0.0% | +15,058 |
| Harris Associates L P | 2,756,781 | $72.6M | 0.1% | −505,115 |
| Bank Of America Corp /de/ | 2,743,403 | $72.3M | 0.0% | +552,918 |
| Deerfield Management Company, L.P. | 2,210,100 | $58.2M | 0.7% | No change |
| UBS Group AG | 2,120,131 | $55.9M | 0.0% | +1,339,174 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jun 6, 2024 | Pete SessionsRepublican, House | Sale | $1,001 - $15,000 | +16.9% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Links
- Websiteenvistaco.com1
- Instagramwww.instagram.com/envistaholdingscorporation1
- LinkedInwww.linkedin.com/company/envista-co1
- WikidataQ106295182
- SEC EDGARCIK 1757073
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5Company websiteEnvista Holdings Corporation photo
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARRobert Befidi, President
- 18SEC EDGARStefan Nilsson, President
- 19SEC EDGARVeronica Acurio, President
- 20
- 21
- 22SEC EDGARCoree K. Thomas, CAO
- 23SEC EDGAREric Conley, SVP, Orthodontics
- 24
- 25
- 26
- 27
- 28
- 29SEC EDGARKari Lyn Moore, Vice President, CAO
- 30SEC EDGARMischa Reis, Senior Vice President
- 31
- 32SEC EDGARJames Andrew Pierce, Board member
- 33SEC EDGARBarbara B. Hulit, Board member
- 34SEC EDGARTeresa Gayle Sheppard, Board member
- 35SEC EDGARDaniel Raskas, Board member
- 36SEC EDGARWilliam K. Daniel, Board member
- 37SEC EDGARAllison F. Blackwell, Board member
- 38SEC EDGARChristine A. Tsingos, Board member
- 39SEC EDGARDan Houghton, Board member
- 40SEC EDGARJonathan O. Clark, Board member
- 41SEC EDGARR. Scott Huennekens, Board member
- 42SEC EDGARWendy Carruthers, Board member
- 43SEC EDGARKieran Gallahue, Board member
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55